Tourmaline Oil Corp. closed 2.2% short of its 52-week high of C$70.65, which the company reached on January 10th.

Investment analysts at Leerink Partnrs increased their FY2024 earnings per share (EPS) estimates for Tourmaline Bio in a ...

What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

Discovered in Brazil in the 80s, these stones are bringing new colour to high jewellery collections In September a cushion-shaped 5.44-carat Paraiba tourmaline ring flew past its US$60,000 upper ...

Just think about the savvy investors who held Tourmaline Oil Corp. (TSE:TOU) shares for the last five years, while they gained 385%. And this is just one example of the epic gains achieved by some ...

Tourmaline Oil Corp. closed 4.7% below its 52-week high of C$70.65, which the company reached on January 10th.

Shares of Tourmaline Oil Corp. (TSE:TOU – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are covering the firm, Marketbeat reports.

The Full Moon in February 2025 is significant for manifesting abundance and personal growth. Crystals such as Citrine, Amethyst, Black Tourmaline, Gre ...

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve ...

In September a cushion-shaped 5.44-carat Paraiba tourmaline ring flew past its US$60,000 upper estimate in auction at Bonhams New York to sell for US$533,900. This is bidding territory more ...